CTOs on the Move

Candel Therapeutics

www.candeltx.com

 
Also known as Advantagene. Inc., we are a Massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our Gene Mediated Cytotoxic (GMCI™) platform and our rQNestin34.5 platform. GMCI™ is an "off-the-shelf"​ immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.candeltx.com
  • 117 Kendrick Street Suite 450
    Needham, MA USA 02494
  • Phone: 617.916.5445

Executives

Name Title Contact Details
Seshu Tyagarajan
 Chief Technical and Development Officer Profile

Funding

Candel Therapeutics raised $22.5M on 04/01/2019
Candel Therapeutics raised $25M on 03/01/2022

Similar Companies

Center for Functional Genomics

Center for Functional Genomics is a Rensselaer, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioAge Labs

BIOAGE has a diverse team of computational biologists and medical scientists with expertise in aging and translational research. We share the vision that a synergy of machine learning approaches, high throughput human omics data, and new experimental approaches will make it possible to discover therapies that address unmet medical needs in an aging population.

Shasqi

Shasqi develops cancer treatment intended to use bio-orthogonal chemistry for localized drug delivery.

Arzeda

Arzeda The Protein Design Company is a synthetic biology company.

Human Genome Sciences

Human Genome Sciences, Inc. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.